Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Acta Neuropathologica Communications|March 25, 2022
DNA methylation-based age acceleration observed in IDH wild-type glioblastoma is associated with better outcome-including in elderly patientsPierre Bady, Christine Marosi, Michael Weller, et al.
Human Reproduction (Oxford, England)|March 12, 2016
Growth trajectories of the human embryonic head and periconceptional maternal conditionsI V Koning, L Baken, I A L Groenenberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 23, 2013
Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with cautionSandra H E Boots-Sprenger, Angelique Sijben, Jos Rijntjes, et al.
Journal of Neuro-Oncology|October 29, 2013
Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivorsEsther J J Habets, Martin J B Taphoorn, Sylvie Nederend, et al.
Neurology|November 26, 2009
IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomideH J Dubbink, W Taal, R van Marion, et al.
The Lancet. Haematology|June 4, 2026
Diagnosis of primary CNS lymphoma through molecular and immune biomarkers in cerebrospinal fluid (PRICELUS): a multicentre, prospective, cohort studyJosephus L M van Rooij, Peter H Wessels, Johanna M Niers, et al.
Journal of Neuro-Oncology|March 15, 2023
Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocolL Bleeker, M C M Kouwenhoven, I de Heer, et al.
Genome Biology|September 24, 2014
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomasHinke F van Thuijl, Ilari Scheinin, Daoud Sie, et al.
Pageof 5